Park et al., 2015 - Google Patents
Control of mammalian G protein signaling by N-terminal acetylation and the N-end rule pathwayPark et al., 2015
View HTML- Document ID
- 2562321267757535300
- Author
- Park S
- Kim J
- Seok O
- Cho H
- Wadas B
- Kim S
- Varshavsky A
- Hwang C
- Publication year
- Publication venue
- Science
External Links
Snippet
Rgs2, a regulator of G proteins, lowers blood pressure by decreasing signaling through Gαq. Human patients expressing Met-Leu-Rgs2 (ML-Rgs2) or Met-Arg-Rgs2 (MR-Rgs2) are hypertensive relative to people expressing wild-type Met-Gln-Rgs2 (MQ-Rgs2). We found …
- 230000037361 pathway 0 title abstract description 90
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Park et al. | Control of mammalian G protein signaling by N-terminal acetylation and the N-end rule pathway | |
| Gu et al. | SAMTOR is an S-adenosylmethionine sensor for the mTORC1 pathway | |
| Yen et al. | Global protein stability profiling in mammalian cells | |
| Nguyen et al. | Control of protein degradation by N-terminal acetylation and the N-end rule pathway | |
| Choudhary et al. | Lysine acetylation targets protein complexes and co-regulates major cellular functions | |
| Ren et al. | Structure-guided discovery of selective antagonists for the chromodomain of polycomb repressive protein CBX7 | |
| Mund et al. | Peptide and small molecule inhibitors of HECT-type ubiquitin ligases | |
| Bridges et al. | 14-3-3 proteins: a number of functions for a numbered protein | |
| Nateri et al. | The ubiquitin ligase SCFFbw7 antagonizes apoptotic JNK signaling | |
| Zorro Shahidian et al. | Succinylation of H3K122 destabilizes nucleosomes and enhances transcription | |
| Tasaki et al. | The mammalian N-end rule pathway: new insights into its components and physiological roles | |
| Tzivion et al. | 14-3-3 proteins: active cofactors in cellular regulation by serine/threonine phosphorylation | |
| Chesnokova et al. | Kinases of eIF2a switch translation of mRNA subset during neuronal plasticity | |
| Samara et al. | Structural insights into the assembly and function of the SAGA deubiquitinating module | |
| Chowdhry et al. | Nrf2 is controlled by two distinct β-TrCP recognition motifs in its Neh6 domain, one of which can be modulated by GSK-3 activity | |
| Rebowski et al. | Mechanism of actin N-terminal acetylation | |
| Hwang et al. | N-terminal acetylation of cellular proteins creates specific degradation signals | |
| Scott et al. | N-terminal acetylation acts as an avidity enhancer within an interconnected multiprotein complex | |
| Su et al. | Polycomb group protein ezh2 controls actin polymerization and cell signaling | |
| Cheng et al. | Interaction of cyclin-dependent kinase 12/CrkRS with cyclin K1 is required for the phosphorylation of the C-terminal domain of RNA polymerase II | |
| Antico et al. | Global ubiquitylation analysis of mitochondria in primary neurons identifies endogenous Parkin targets following activation of PINK1 | |
| Ohsaki et al. | The role of β-TrCP1 and β-TrCP2 in circadian rhythm generation by mediating degradation of clock protein PER2 | |
| Hu et al. | A minimal RNA polymerase III transcription system from human cells reveals positive and negative regulatory roles for CK2 | |
| Villamil et al. | Serine phosphorylation is critical for the activation of ubiquitin-specific protease 1 and its interaction with WD40-repeat protein UAF1 | |
| Smith et al. | The ins and outs of transcriptional control: nucleocytoplasmic shuttling in development and disease |